BlackRock Health Sciences Trust - COM (BME)

Historical Holders from Q1 2014 to Q3 2025

Symbol
BME on NYSE
Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2,850,013
Holdings value
$106,060,783
% of all portfolios
0%
Number of holders
75
Number of buys
36
Number of sells
-31
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of BlackRock Health Sciences Trust - COM (BME)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 2,850,013 $106,060,783 +$347,635 $37.23 75
2025 Q2 2,832,533 $103,266,015 +$1,240,591 $36.46 69
2025 Q1 2,795,302 $107,695,503 -$11,214,825 $38.64 67
2024 Q4 3,086,991 $117,435,803 -$6,393,312 $37.93 73
2024 Q3 3,264,129 $136,855,957 +$1,057,080 $41.93 73
2024 Q2 3,227,476 $131,832,684 +$8,746,856 $40.85 70
2024 Q1 3,012,706 $124,926,298 +$3,026,609 $41.44 73
2023 Q4 2,940,931 $118,993,662 +$6,287,075 $40.46 74
2023 Q3 2,774,841 $108,625,635 +$7,659,849 $39.15 73
2023 Q2 2,550,709 $103,647,396 -$2,064,498 $40.64 69
2023 Q1 2,601,389 $108,905,374 +$760,483 $41.86 71
2022 Q4 2,585,202 $112,595,323 +$7,062,960 $43.58 72
2022 Q3 2,394,779 $92,991,116 +$2,895,064 $38.82 60
2022 Q2 2,316,083 $98,173,921 +$6,940,824 $42.39 60
2022 Q1 2,134,131 $97,165,293 -$993,240 $45.52 58
2021 Q4 2,146,983 $104,124,392 +$1,669,710 $48.5 59
2021 Q3 1,580,664 $75,313,661 -$1,196,047 $47.65 54
2021 Q2 1,605,475 $77,865,260 +$3,500,725 $48.5 57
2021 Q1 1,563,021 $72,279,350 +$5,433,801 $46.25 51
2020 Q4 1,413,045 $67,158,305 +$5,986,080 $47.59 51
2020 Q3 1,284,437 $55,037,325 -$1,417,869 $42.86 46
2020 Q2 1,297,519 $52,948,243 +$6,012,305 $40.78 45
2020 Q1 1,150,908 $41,485,675 +$5,572,498 $36.05 40
2019 Q4 989,858 $42,056,478 +$3,273,433 $42.48 42
2019 Q3 899,572 $34,394,000 -$2,906,416 $38.25 41
2019 Q2 973,643 $37,871,000 +$2,512,830 $38.89 43
2019 Q1 909,437 $36,189,000 +$1,850,427 $39.79 41
2018 Q4 862,267 $31,447,000 -$487,259 $36.42 42
2018 Q3 866,222 $36,843,166 +$3,930,497 $42.53 43
2018 Q2 774,286 $29,856,000 -$2,732,331 $38.58 38
2018 Q1 855,303 $29,910,000 -$14,610,290 $35 39
2017 Q4 1,271,341 $46,396,000 +$544,643 $36.5 35
2017 Q3 1,254,806 $45,746,000 +$677,157 $36.45 32
2017 Q2 1,988,553 $48,627,000 +$2,450,032 $36.65 34
2017 Q1 1,260,632 $43,610,000 -$102,524 $34.59 28
2016 Q4 1,265,022 $40,190,000 -$1,398,344 $31.76 34
2016 Q3 1,309,137 $44,947,000 +$2,282,838 $34.36 35
2016 Q2 1,242,801 $44,286,000 -$665,842 $35.62 32
2016 Q1 1,239,451 $43,959,000 -$778,195 $35.46 31
2015 Q4 1,264,788 $49,662,000 -$640,094 $39.35 25
2015 Q3 1,272,924 $47,910,000 -$1,364,588 $37.56 24
2015 Q2 1,307,395 $56,041,496 -$224,564 $42.8 26
2015 Q1 1,308,826 $56,240,241 -$6,420,742 $43 25
2014 Q4 1,463,343 $62,266,372 -$784,854 $42.7 29
2014 Q3 1,489,040 $57,135,200 +$381,421 $38.38 29
2014 Q2 1,478,019 $54,071,366 +$1,605,528 $36.73 28
2014 Q1 1,434,286 $52,886,117 -$3,516,976 $37.02 26